Skip to main content

Advertisement

SpringerLink
Log in

Incorporating Nutrition-Based Strategies into IBD Treatment

  • Inflammatory Bowel Disease (B Cohen, Section Editor)
  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Diet and nutrition have emerged as key factors in the development and course of inflammatory bowel disease (IBD), including the approach to therapy. We present an overview of evidence-based recommendations and recent research in dietary therapy and nutrition management for patients with IBD.

Recent Findings

Patients with IBD should undergo a comprehensive nutrition assessment with the assistance of a registered dietitian (RD), including screening for micronutrient deficiencies. Multiple specialized whole foods and liquid formula diets have been evaluated as part of induction and maintenance therapy for IBD. Nutritional status should ideally be optimized in the perioperative setting as well.

Summary

Nutritional issues are prevalent among IBD patients and should be addressed by a multidisciplinary team, tailored to each patient’s disease type, severity and course, including response to medical therapy and need for surgical management, as well as relevant psychosocial considerations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Chang J. Pathophysiology of inflammatory bowel diseases. N Engl J Med. 2020;383(27):2652–64. https://doi.org/10.1056/NEJMra2002697.

    Article  CAS  Google Scholar 

  2. Lewis JD, Abreu M. Diet as a trigger or therapy for inflammatory bowel diseases. Gastroenterology. 2017;152(2):398-414.e6. https://doi.org/10.1053/j.gastro.2016.10.019.

    Article  CAS  Google Scholar 

  3. Who.int. 2022. Fact sheets - Malnutrition. [online] Available at: https://www.who.int/news-room/fact-sheets/detail/malnutrition. Accessed 19 Sept 2022.

  4. •• Fitzpatrick JA, Melton S, Yao C, et al. Dietary management of adults with IBD — the emerging role of dietary therapy. Nat Rev Gastroenterol Hepatol 2022:1–18. https://doi.org/10.1038/s41575-022-00619-5. Recent comprehensive review of approach to nutritional assessment and management in IBD patients.

  5. Singh S, Dulai PS, Zarrinpar A, et al. Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol 2017:14(2):110–21. https://doi.org/10.1038/nrgastro.2016.181.

  6. Ludvigsson JF, Olén O, Larrson H, et al. Association between inflammatory bowel disease and psychiatric morbidity and suicide: a Swedish nationwide population-based cohort study with sibling comparisons. J Crohns Colitis 2021:15:1824–36. https://doi.org/10.1093/ecco-jcc/jjab039.

  7. Ilzarbe L, Fàbrega M, Quintero J, et al. Inflammatory bowel disease and eating disorders: a systematized review of comorbidity. J Psychosom Res 2017:102:47–53. https://doi.org/10.1016/j.jpsychores.2017.09.006.

  8. Bryant RV, Schultz CG, Ooi Soong, et al. Obesity in inflammatory bowel disease: gains in adiposity despite high prevalence of myopenia and osteopenia. Nutrients 2018:10:1192. https://doi.org/10.3390/nu10091192.

  9. Fearon K, Evans WJ, Anker SD. Myopenia–a new universal term for muscle wasting. J. Cachexia Sarcopenia Muscle 2011:2:1–3. https://doi.org/10.1007/s13539-011-0025-7.

  10. Bryant RV, Ooi S, Schultz CG, et al. Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther. 2015;41:895–906. https://doi.org/10.1111/apt.13156.

    Article  CAS  Google Scholar 

  11. Wood J, Ward L, Sparrow M, et al. Utility of bioimpedance methods for the assessment of fat-free mass in adult outpatients with inflammatory bowel disease. Nutrition. 2020;77:110833. https://doi.org/10.1016/j.nut.2020.110833.

    Article  CAS  Google Scholar 

  12. •• Ananthakrishnan A, Kaplan G, Bernstein CN, et al. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an international organization for study of inflammatory bowel diseases consensus. Lancet Gastroenterol Hepatol 2022:7(7):666–678. https://doi.org/10.1016/S2468-1253(22)00021-8. Recent overview of lifestyle, including dietary modifications, as part of IBD therapy.

  13. •• Hou JK, Gasche C, Drazin NZ, et al. Assessment of gaps in care and the development of a care pathway for anemia in patients with inflammatory bowel diseases. Inflamm Bowel Dis 2017:23(1):35–43. https://doi.org/10.1097/MIB.0000000000000953. Crohn’s and Colitis Foundation Anemia Care Pathway.

  14. •• Mahadevan U, Robinson C, Bernasko N, et al. Inflammatory bowel disease in pregnancy clinical care pathway: a report from the american gastroenterological association IBD parenthood project working group. Inflamm Bowel Dis 2019:25(4):627–41. https://doi.org/10.1053/j.gastro.2018.12.022. Multisociety guideline for management of fertility, pregnancy and lactation in IBD.

  15. Hwang C, Ross V, Mahadevan U. Inflamm Bowel Dis. 2012;18(10):1961–81. https://doi.org/10.1002/ibd.22906.

    Article  Google Scholar 

  16. •• Levine A, Rhodes JM, Lindsay JO, et al. Dietary guidance from the international organization for the study of inflammatory bowel diseases. Clin Gastroenterol Hepatol 2020:18(6):1381–92. https://doi.org/10.1016/j.cgh.2020.01.046. IOIBD dietary guidelines for IBD.

  17. Limketkai BN, Iheozor-Ejiofor Z, Gjuladin‐Hellon T, et al. Dietary interventions for induction and maintenance of remission in inflammatory bowel disease. Cochrane Database Syst Rev 2019(2). Art. No.: CD012839. https://doi.org/10.1002/14651858.CD012839.pub2.

  18. •• Bischoff SC, Escher J, Hébuterne X, et al. ESPEN practical guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr 2020:39:632–53. https://doi.org/10.1016/j.clnu.2019.11.002. Evidence-based nutrition guidelines for IBD from the European Society for Clinical Nutrition and Metabolism.

  19. Cox S, Lindsay J, Fromentin S, et al. Effects of Low FODMAP Diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial. Gastroenterology 2020:158(1):176–188. https://doi.org/10.1053/j.gastro.2019.09.024.

  20. Fujiya M, Ueno N, Kohgo Y. Probiotic treatments for induction and maintenance of remission in inflammatory bowel diseases: a meta-analysis of randomized controlled trials. Clin J Gastroenterol 2014:7(1)e13. https://doi.org/10.1007/s12328-013-0440-8.

  21. Lewis JD, Sandler RS, Brotherton C, et al. A randomized trial comparing the specific carbohydrate diet to a Mediterranean diet in adults with Crohn’s disease. Gastroenterology 2021:161:837–52.e9. https://doi.org/10.1053/j.gastro.2021.05.047.

  22. Konijeti GG, Kim N, Groven S, et al. Efficacy of the autoimmune protocol diet for inflammatory bowel disease. Inflamm Bowel Dis 2017:23:2054–60. https://doi.org/10.1097/MIB.0000000000001221.

  23. Sarbagili-Shabat C, Albenberg L, Van Limbergen J, et al. A novel UC exclusion diet and antibiotics for treatment of mild to moderate pediatric ulcerative colitis: a prospective open-label pilot study. Nutrients 2021:13:3736. https://doi.org/10.3390/nu13113736.

  24. Levine A, Scaldaferri F, Sarbagili Shabat C, et al. OP01 Comparison of fecal transplantation, fecal transplantation with the novel UC diet or the UC diet alone for Refractory Mild to Moderate Active Ulcerative Colitis: The CRAFT UC randomized controlled trial. J Crohn’s Colitis. 2021;15(Supplement 1):001. https://doi.org/10.1093/ecco-jcc/jjab165.

    Article  Google Scholar 

  25. Levine A, Wine E, Assa A, et al. Crohn’s disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial. Gastroenterology 2019:157:440–50.e8. https://doi.org/10.1053/j.gastro.2019.04.021.

  26. Chicco F, Magrì S, Cingolani A, et al. Multidimensional impact of mediterranean diet on IBD patients. Inflamm Bowel Dis. 2020;27(1):1–9. https://doi.org/10.1093/ibd/izaa097.

    Article  Google Scholar 

  27. Sandall AM, Cox SR, Lindsay JO, et al. Emulsifiers impact colonic length in mice and emulsifier restriction is feasible in people with Crohn’s disease. Nutrients 2020:12:2827. https://doi.org/10.3390/nu12092827.

  28. Yao C, Muir J, Gibson P. Review article: insights into colonic protein fermentation, its modulation and potential health implications. Aliment Pharmacol Ther. 2015;43(2):181–96. https://doi.org/10.1111/apt.13456.

    Article  CAS  Google Scholar 

  29. Bock S. AAAAI support of the EAACI Position Paper on IgG4. J Allergy Clin Immunol. 2010;125(6):1410. https://doi.org/10.1016/j.jaci.2010.03.013.

    Article  Google Scholar 

  30. Ruemmele FM, Veres G, Kolho KL, et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J Crohn’s Colitis 2014:8:1179–1207. https://doi.org/10.1016/j.crohns.2014.04.005.

  31. van Rheenen PF, Aloi M, Assa A, et al. The medical management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update. J Crohn’s Colitis 2021:15(2):171–94. https://doi.org/10.1093/ecco-jcc/jjaa161.

  32. Hirai F, Takeda T, Takada Y, et al. Efficacy of enteral nutrition in patients with Crohn’s disease on maintenance anti-TNF-alpha antibody therapy: a meta-analysis. J Gastroenterol 2020:55(2):133–41. https://doi.org/10.1007/s00535-019-01634-1.

  33. Lee GC, Hodin RA. Applying enhanced recovery pathways to unique patient populations. Clin Colon Rectal Surg. 2019;32(2):134–137. https://doi.org/10.1055/s-0038-1676479.

    Article  Google Scholar 

  34. Abdalla S, Benoist S, Maggiori L, et al. Impact of preoperative enteral nutritional support on postoperative outcome in patients with Crohn’s disease complicated by malnutrition. Colorectal Dis 2021:23:1451–62. https://doi.org/10.1111/codi.15600.

  35. Meade S, Patel KV, Luber RP, et al. A retrospective cohort study: Pre-operative oral enteral nutritional optimisation for Crohn’s disease in a UK tertiary IBD Centre. Aliment Pharmacol Ther 2022:56:646–63. https://doi.org/10.1111/apt.17055.

  36. Heerasing N, Thompson B, Hendy P, et al. Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn’s disease. Aliment Pharmacol Ther 2017:45:660–69. https://doi.org/10.1111/apt.13934.

  37. Adamina M, Bonovas S, Raine T, et al. European Crohn’s and Colitis Organisation [ECCO], ECCO guidelines on therapeutics in Crohn’s Disease: surgical treatment. J Crohn’s Colitis 2020:14(2):155–68. https://doi.org/10.1093/ecco-jcc/jjz187.

  38. Feldman LS, Delaney CP, Ljungqvist O, et al. The SAGES / ERAS Society Manual of Enhanced Recovery Programs for Gastrointestinal Surgery. Cham: Springer International Publishing; 2015.

    Book  Google Scholar 

  39. Fiorindi C, Cuffaro F, Piemonte G, et al. Effect of long-lasting nutritional prehabilitation on postoperative outcome in elective surgery for IBD. Clin Nutr. 2021;40(3):928–35. https://doi.org/10.1016/j.clnu.2020.06.020.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Scripps Clinic, 10666 N Torrey Pines Rd. Box 403C, La Jolla, CA, 92037, USA

    Pooja R. Magavi, Lori A. Beeken, Rebecca Matro, Mazer Ally, Melissa J. Ferrari & Gauree G. Konijeti

Authors
  1. Pooja R. Magavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lori A. Beeken
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rebecca Matro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mazer Ally
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Melissa J. Ferrari
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gauree G. Konijeti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gauree G. Konijeti.

Ethics declarations

Conflict of Interest

Pooja R. Magavi declares no potential conflict of interest.

Lori A. Beeken declares no potential conflict of interest.

Rebecca Matro is on the speakers bureau for AbbVie.

Mazer Ally is on the speakers bureau for AbbVie.

Melissa J. Ferrari declares no potential conflict of interest.

Gauree G. Konijeti is on the advisory board for Pfizer & ProciseDx and the speakers bureau for Takeda.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Inflammatory Bowel Disease

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Magavi, P.R., Beeken, L.A., Matro, R. et al. Incorporating Nutrition-Based Strategies into IBD Treatment. Curr Gastroenterol Rep 24, 183–190 (2022). https://doi.org/10.1007/s11894-022-00851-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-022-00851-8

Keywords

Search

Navigation